BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10729995)

  • 1. Effects of cyclosporin A on refractory B-cell chronic lymphocytic leukemia.
    Nishii K; Katayama N; Mitani H; Matsumoto T; Miwa H; Kita K; Shiku H
    Int J Hematol; 2000 Jan; 71(1):59-65. PubMed ID: 10729995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansions of clonal and oligoclonal T cells in B-cell chronic lymphocytic leukemia are primarily restricted to the CD3(+)CD8(+) T-cell population.
    Goolsby CL; Kuchnio M; Finn WG; Peterson L
    Cytometry; 2000 Jun; 42(3):188-95. PubMed ID: 10861692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
    Scamardella F; Maconi M; Albertazzi L; Gamberi B; Gugliotta L; Brini M
    Lab Hematol; 2006; 12(4):187-92. PubMed ID: 17118768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
    Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
    Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. True small lymphocytic T-cell chronic lymphocytic leukemia lacking the CD3 molecule and TCR-alpha beta on its cell surface.
    Murakami K; Taketazu F; Ida M; Ito K; Yamazaki I; Oshimi K; Kanazawa Y; Kawakami M
    Int J Hematol; 1999 Oct; 70(3):169-73. PubMed ID: 10561909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
    Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
    Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular IFN-gamma expression by CD3+/CD8+ cell subset in B-CLL patients correlates with stage of the disease.
    Podhorecka M; Dmoszynska A; Rolinski J
    Eur J Haematol; 2004 Jul; 73(1):29-35. PubMed ID: 15182335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
    Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered constitutive and activation-induced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia.
    De Fanis U; Dalla Mora L; Romano C; Sellitto A; Tirelli A; Lucivero G
    Haematologica; 2002 Mar; 87(3):325-7. PubMed ID: 11869948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
    Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
    Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia.
    Allgeier T; Garhammer S; Nössner E; Wahl U; Kronenberger K; Dreyling M; Hallek M; Mocikat R
    Cancer Lett; 2007 Jan; 245(1-2):275-83. PubMed ID: 16516377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A further characterization of B-CLL lymphocytes: phenotypic and functional studies.
    Merle-Béral H
    Nouv Rev Fr Hematol (1978); 1990; 32(5):319-21. PubMed ID: 2099403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
    Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
    Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
    Abousamra NK; El-Din MS; Azmy E
    Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia.
    Eisele L; Haddad T; Sellmann L; Dührsen U; Dürig J
    Leuk Res; 2009 Jun; 33(6):775-8. PubMed ID: 18922578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells CD19+ in patients with B-cell chronic lymphocytic leukaemia and autoimmune haemolytic anaemia.
    Słomkowski M; Kopeć-Szlezak J; Fabijańska-Mitek J; Podstawka U; Sikorska A; Mendek-Czajkowska E
    Clin Lab Haematol; 2004 Dec; 26(6):385-9. PubMed ID: 15595995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant phenotypic expression of the T-cell-associated antigen CD8 on B-cell chronic lymphocytic leukemia cells.
    Stagno F; Triolo A; Del Fabro V; Berretta S; Parrinello NL; Fargione G; Di Raimondo F
    Lab Hematol; 2009; 15(1):1-3. PubMed ID: 19273392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemia.
    Consoli U; El-Tounsi I; Sandoval A; Snell V; Kleine HD; Brown W; Robinson JR; DiRaimondo F; Plunkett W; Andreeff M
    Blood; 1998 Mar; 91(5):1742-8. PubMed ID: 9473241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia.
    Hu C; Xiong J; Zhang L; Huang B; Zhang Q; Li Q; Yang M; Wu Y; Wu Q; Shen Q; Gao Q; Zhang K; Sun Z; Liu J; Jin Y; Tan J
    Cell Mol Immunol; 2004 Aug; 1(4):280-94. PubMed ID: 16225771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.